OpenLegislation

Paragraph 169 I1

United Kingdom

In regulation 213 (amendment of regulation 281 (duties of authorisation holders and registration holders)) for paragraphs (b) and (c) substitute—

“(b)

omit “or” at the end of sub-paragraph (c); and

(c)

in sub-paragraph (d), after “for a medicinal product” insert—

“; or

(e)

an EU marketing authorisation for a medicinal product.”.”.

Annotations

Commencement

I1

Sch. 2 para. 169 in force at 31.12.2020 immediately before IP completion day, see reg. 1